Skip to main navigation

Home
Overview
News & Publications
News Releases Publications
Events & Presentations
Governance
Documents & Charters Leadership and Board Committee Composition
Stock
Stock Quote & Chart Analyst Coverage
Financials
SEC Filings
IR Resources
Email Alerts Contact Us

Events and Presentations

Presentations

April 19, 2022

Presentation for Third Annual International Conference on Cell and Experimental Biology 2022 2.9 MB

Past Events

May 25, 2022

Novel Immunotherapeutics for Cancer and Other Age Related Diseases

Novel Immunotherapeutics for Cancer and Other Age Related Diseases 2.5 MB

May 9, 2022

Robust human regulatory T cell expansion with fusion proteins HCW9302 and HCW9213 circumvents need for magnetic-bead or feeder cell approaches for adoptive cell therapy – Immunology 2022

Robust human regulatory T cell expansion with fusion proteins HCW9302 and HCW9213 circumvents need for magnetic-bead or feeder cell approaches for adoptive cell therapy – Immunology 2022 942.9 KB

May 9, 2022

A “kick and expand” strategy to generate large numbers of CIML NK cells for adoptive cell therapy for the treatment of cancer using novel fusion proteins HCW9201 and HCW9206 – Immunology 2022

A “kick and expand” strategy to generate large numbers of CIML NK cells for adoptive cell therapy for the treatment of cancer using novel fusion proteins HCW9201 and HCW9206 – Immunology 2022 1.1 MB

Jan 19, 2022

Video: Dr. Hing C. Wong’s Presentation at the 21st Annual PepTalk 2022

Jan 11, 2022

Extending Health Span with Focus on Chronic Inflammation Induced by Chemotherapy Used to Treat Age-Related Diseases with Dr. Hing Wong HCW Biologics on Empowered Patient Podcast with Karen Jagoda

Listen to podcast

Transcript 211.5 KB

Jan 6, 2022

The Bio Report with Daniel Levine - Targeting Chronic, Low-Grade Inflammation to Address Diseases of Aging – Hing C. Wong, Ph.D.

Listen to podcast

Nov 19, 2021

EF Hutton Initiates Coverage on HCW Biologics with Buy Rating

Oct 28, 2021

HCW Biologics shares leap higher on pancreatic cancer program progress - BioWorld

Oct 13, 2021

HCW Biologics and the treatment of Inflammaging, Interview with Dr. Peter Rhode on Health Professional Radio

Sep 20, 2021

HCW Biologics Inc.(NasdaqGM:HCWB) added to S&P TMI Index

Pagination

Current page 1
Page 2
Next page
Last page

© HCW Biologics, Inc. 2021 - 2022